Alector, Inc.
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
ALEC | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 131 OYSTER POINT BLVD., SUITE 600, 94080 SOUTH SAN FRANCISCO
- Website:
- https://alector.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alector, Inc. is a clinical-stage biotechnology company that pioneers immuno-neurology, a therapeutic approach for treating neurodegenerative diseases. The company leverages insights from human genetics, neuroscience, and immunology to develop a pipeline of potential first-in-class and best-in-class medicines. Alector's scientific approach focuses on harnessing the brain's innate immune system to restore function. Its therapeutic candidates are designed to repair genetic mutations, remove toxic proteins, and replace deficient proteins to slow or halt the progression of conditions like Alzheimer's disease and other forms of dementia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Alector, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alector, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alector, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
